Article Details
Retrieved on: 2021-02-02 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on development of first-in-class oncology drugs, today announced a ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here